andrew huberman bpc-157 Comment PEPTIDES & I'll DM you a link to the episode. PEPTIDES MASTERCLASS • Andrew Huberman consults an expert

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

While supplementation may provide symptomatic benefits, an appropriate dosage has yet to be determined

Crucially, FOXO4-DRI selectively induced apoptosis in senescent TM3 Leydig cells by causing nuclear exclusion of active Ser15-phospho-p53, leading to a significant increase in apoptosis rate and altering pro-apoptotic (BAX, cleaved-Caspase3 increase) and anti-apoptotic (BCL-2 decrease) protein levels

Neuropharmacology 26:385390 Sikiric P, Petek M, Rucman R et al (1993) A new gastric juice peptide, BPC.An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC

Nakashima, S